A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
Clinical trial NCT06920771 · COMPLETED
Trial details
- NCT number
- NCT06920771
- Sponsor
- HAL Allergy
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2026-03-30
- Enrollment
- 691
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.